Xuan Marian Thai

Array ( [id] => 6014842 [patent_doc_number] => 20110223165 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-15 [patent_title] => 'Humanized C-Kit Antibody' [patent_app_type] => utility [patent_app_number] => 13/046463 [patent_app_country] => US [patent_app_date] => 2011-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 19992 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0223/20110223165.pdf [firstpage_image] =>[orig_patent_app_number] => 13046463 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8293974 [patent_doc_number] => 08221756 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-07-17 [patent_title] => 'Complement inhibitors and uses thereof' [patent_app_type] => utility [patent_app_number] => 13/045895 [patent_app_country] => US [patent_app_date] => 2011-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 4997 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 87 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13045895 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7697101 [patent_doc_number] => 20110229489 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-22 [patent_title] => 'Antibodies with pH Dependent Antigen Binding' [patent_app_type] => utility [patent_app_number] => 13/045345 [patent_app_country] => US [patent_app_date] => 2011-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 32610 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0229/20110229489.pdf [firstpage_image] =>[orig_patent_app_number] => 13045345 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8585670 [patent_doc_number] => 20130004491 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-01-03 [patent_title] => 'Antibodies Against Phosphorylcholine In Combination Therapy with Biologic Agents' [patent_app_type] => utility [patent_app_number] => 13/582193 [patent_app_country] => US [patent_app_date] => 2011-03-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 14771 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13582193 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5969068 [patent_doc_number] => 20110150890 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-23 [patent_title] => 'USE OF CGRP ANTAGONIST COMPOUNDS FOR TREATMENT OF PSORIASIS' [patent_app_type] => utility [patent_app_number] => 13/039075 [patent_app_country] => US [patent_app_date] => 2011-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 7643 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0150/20110150890.pdf [firstpage_image] =>[orig_patent_app_number] => 13039075 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8652879 [patent_doc_number] => 08372625 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-02-12 [patent_title] => 'Polynucleotides encoding antagonist antibodies against GDF-8' [patent_app_type] => utility [patent_app_number] => 13/038954 [patent_app_country] => US [patent_app_date] => 2011-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 39 [patent_no_of_words] => 33154 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13038954 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8152441 [patent_doc_number] => 08168761 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-05-01 [patent_title] => 'Antibody to SOST peptides' [patent_app_type] => utility [patent_app_number] => 13/030703 [patent_app_country] => US [patent_app_date] => 2011-02-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 69 [patent_no_of_words] => 17757 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/168/08168761.pdf [firstpage_image] =>[orig_patent_app_number] => 13030703 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8591452 [patent_doc_number] => 08349327 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-01-08 [patent_title] => 'Method for treating muscular dystrophy using antagonist antibodies against GDF-8' [patent_app_type] => utility [patent_app_number] => 13/030978 [patent_app_country] => US [patent_app_date] => 2011-02-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 39 [patent_no_of_words] => 33150 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 109 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13030978 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8779631 [patent_doc_number] => 20130101606 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-04-25 [patent_title] => 'Novel Phosphorylation of Cardiac Troponin I as a Monitor for Cardiac Injury' [patent_app_type] => utility [patent_app_number] => 13/579797 [patent_app_country] => US [patent_app_date] => 2011-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 11587 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13579797 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9375981 [patent_doc_number] => 08680246 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-03-25 [patent_title] => 'Antibodies that bind to lysyl oxidase-like 2 (LOXL2)' [patent_app_type] => utility [patent_app_number] => 13/021555 [patent_app_country] => US [patent_app_date] => 2011-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 6 [patent_no_of_words] => 40685 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13021555 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9843651 [patent_doc_number] => 08945563 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-02-03 [patent_title] => 'Method for treating glioblastoma using antibodies binding to the extracellular domain of the receptor tyrosine kinase ALK' [patent_app_type] => utility [patent_app_number] => 13/017925 [patent_app_country] => US [patent_app_date] => 2011-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 13485 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13017925 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8502061 [patent_doc_number] => 20120301470 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-11-29 [patent_title] => 'USE OF TYROSINE KINASE INHIBITORS FOR TREATMENT OF CUSHING\'S DISEASE AND HYPERCORTISOLISM' [patent_app_type] => utility [patent_app_number] => 13/576621 [patent_app_country] => US [patent_app_date] => 2011-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 10856 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13576621 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7487442 [patent_doc_number] => 20110236384 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-29 [patent_title] => 'DIRECT DRUG DELIVERY SYSTEM BASED ON THERMALLY RESPONSIVE BIOPOLYMERS' [patent_app_type] => utility [patent_app_number] => 13/012475 [patent_app_country] => US [patent_app_date] => 2011-01-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 7945 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0236/20110236384.pdf [firstpage_image] =>[orig_patent_app_number] => 13012475 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8445824 [patent_doc_number] => 08287872 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-10-16 [patent_title] => 'Methods for treating inflammatory conditions using antibodies that bind PAR-2' [patent_app_type] => utility [patent_app_number] => 13/008736 [patent_app_country] => US [patent_app_date] => 2011-01-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 19551 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 125 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13008736 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6159589 [patent_doc_number] => 20110158999 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-30 [patent_title] => 'ANTAGONISTS OF PROTEASE ACTIVATED RECEPTOR-1 (PAR1)' [patent_app_type] => utility [patent_app_number] => 12/986989 [patent_app_country] => US [patent_app_date] => 2011-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 19063 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0158/20110158999.pdf [firstpage_image] =>[orig_patent_app_number] => 12986989 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6062208 [patent_doc_number] => 20110200611 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-18 [patent_title] => 'PLASMA KALLIKREIN BINDING PROTEINS' [patent_app_type] => utility [patent_app_number] => 12/985914 [patent_app_country] => US [patent_app_date] => 2011-01-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 78094 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0200/20110200611.pdf [firstpage_image] =>[orig_patent_app_number] => 12985914 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5945112 [patent_doc_number] => 20110105732 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-05 [patent_title] => 'Reagents for the Detection of Protein Phosphorylation in Carcinoma Signaling Pathways' [patent_app_type] => utility [patent_app_number] => 12/985879 [patent_app_country] => US [patent_app_date] => 2011-01-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 20256 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20110105732.pdf [firstpage_image] =>[orig_patent_app_number] => 12985879 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8489100 [patent_doc_number] => 20120288507 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-11-15 [patent_title] => 'WISE BINDING AGENTS AND EPITOPES' [patent_app_type] => utility [patent_app_number] => 13/516161 [patent_app_country] => US [patent_app_date] => 2010-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 25264 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13516161 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8659481 [patent_doc_number] => 20130040310 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-02-14 [patent_title] => 'ULK1 COMPOSITIONS, INHIBITORS, SCREENING AND METHODS OF USE' [patent_app_type] => utility [patent_app_number] => 13/516343 [patent_app_country] => US [patent_app_date] => 2010-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 16610 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13516343 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7810959 [patent_doc_number] => 08133489 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-03-13 [patent_title] => 'Inhibition of macrophage-stimulating protein receptor (RON) and methods of treatment thereof' [patent_app_type] => utility [patent_app_number] => 12/967241 [patent_app_country] => US [patent_app_date] => 2010-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 27 [patent_no_of_words] => 19986 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/133/08133489.pdf [firstpage_image] =>[orig_patent_app_number] => 12967241 [rel_patent_id] =>[rel_patent_doc_number] =>)